|
業務類別
|
Biotechnology |
|
業務概覽
|
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. |
| 公司地址
| 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, USA, 44103 |
| 電話號碼
| +1 646 813-4701 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.abeonatherapeutics.com |
| 員工數量
| 226 |
| Mr. Vishwas Seshadri |
President, Chief Executive Officer and Director |
美元 662.00K |
27/04/2026 |
| Dr. Brendan M. O'Malley, J.D.,PhD |
General Counsel |
美元 456.44K |
27/04/2026 |
| Mr. Madhav Vasanthavada |
Chief Commercial Officer |
-- |
27/04/2026 |
| Mr. Joseph W. Vazzano, C.P.A. |
Chief Financial Officer and Chief Accounting Officer |
美元 475.90K |
27/04/2026 |
|
|
| Mr. Mark J. Alvino |
Independent Director |
27/04/2026 |
| Dr. Leila Alland, M.D. |
Independent Director |
27/04/2026 |
| Ms. Christine Berni Silverstein |
Independent Director |
27/04/2026 |
| Ms. Faith L. Charles, J.D. |
Independent Director |
27/04/2026 |
| Mr. Michael Amoroso |
Chairman of the Board |
27/04/2026 |
| Mr. Donald A. Wuchterl |
Independent Director |
27/04/2026 |
| Mr. Vishwas Seshadri |
President, Chief Executive Officer and Director |
27/04/2026 |
| Dr. Eric Crombez, M.D. |
Independent Director |
27/04/2026 |
| Mr. Keith A. Goldan |
Independent Director |
07/04/2026 |
| Dr. Bernhardt G. Zeiher, F.A.C.P.,F.C.C.P.,M.D. |
Independent Director |
27/04/2026 |
|
|
|
|
